Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 01 December 2016
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
      Highlight of the week
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 
 
 
151216 EFPIA Welcomes new Agreement on General Data Protection Regulation 16 December 2015
 
Read more →
 
 
      News
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 
 
  20 June 2016 160620 Pharmaceutical companies drive transparency and underline industry investment in European...

Over the next ten days, pharmaceutical companies will be disclosing details of collaborations with HCPs and HCOs across...

Read more →
 
 
 
  02 October 2015 151002 EFPIA welcomes Member States sharing experience on new models for patient access

Vytenis Andriukaitis calls for new partnership between pharmaceutical companies and member states.

Read more →
 
 
 
      From our blog
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 
 
  11 August 2011 110811 Visualizing the HPV vaccine

Richard Bergström tells us about a blog, written by David McCandless, on how designed information can help us understand...

Read more →
 
 
 
  02 May 2013 130502 The HIV Story: When Research Faces Setbacks, Look to Previous Advances for Inspiration...

Richard Bergström discusses the third meeting of the International HIV Treatment as Prevention Workshop

Read more →
 
 
 
      Video
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 
 
 
 
Test video title
President Obama congratulates you for everything your generation has done to change the planet. But now it’s showtime. It's time to get out there and vote in real life.
     
 
 
 
      Events
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 
 
 
27 AUG 2013
  A Roadmap for Sharing Clinical Trial Data Brussels Learn more →
 
 
 
16 DEC 2016
  161216 Save the Date: 5th EMA-EBE Regulatory Policy Seminar - "Optimising ATMP development... London, UK Learn more →
 
 
 
06 APR 2016
  160406 DIA 28th Annual EuroMeeting 2016 Hamburg, Germany

A platform to exchange ideas on key challenges facing healthcare

Learn more →
 
 
      Documents
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 
 
      What we are reading
Lorem ipsum dolor sit amet, dicta eirmod inciderint has cu, affert habemus eu qui, ut senserit conceptam vituperatoribus per. Pri ea animal timeam, vel ne deserunt platonem, has ad affert nullam. Ea est case consulatu reprimique. Eu his enim moderatius, modus saperet vix ne, eum te aeque debitis. No est populo dolorum, mollis timeam antiopam quo in, an augue impetus graecis ius. Has et affert iriure scaevola, debitis laboramus tincidunt et vim.
 
Lasers Measure Cells’ Stiffness to Identify Neoplastic Ones 01 March 2017  (www.medgadget.com) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe